NYSEARCA:IHE iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News → Digitizing the $11T commodities sector with one tiny stock (From Resource Stock Digest) (Ad) Free IHE Stock Alerts $65.03 -0.41 (-0.63%) (As of 04:10 PM ET) Add Compare Share Share Today's Range$64.78▼$65.6750-Day Range$62.85▼$67.9052-Week Range$55.36▼$69.56Volume26,279 shsAverage Volume69,252 shsMarket Capitalization$656.80 millionAssets Under Management$673.70 millionDividend Yield5.74%Net Expense Ratio0.39% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get iShares U.S. Pharmaceuticals ETF alerts: Email Address About iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors.Read More IHE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IHE ETF News HeadlinesMay 23, 2024 | msn.comSEC Approves Spot Ether ETFsApril 17, 2024 | finance.yahoo.comJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in FocusApril 10, 2024 | msn.comThis weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?April 4, 2024 | msn.comUnified Action: Biden and Sanders Target Pharma PricingMarch 18, 2024 | seekingalpha.comIHI: Technological Advances Will Continue Carrying This High-Performing Medical ETFFebruary 14, 2024 | msn.comShould You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?February 7, 2024 | finance.yahoo.comETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings BeatJanuary 31, 2024 | uk.investing.comiShares U.S. Pharmaceuticals ETF (IHE)See More Headlines Receive IHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares U.S. Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IHE Inception Date5/1/2006 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason Webwww.iShares.com PhoneN/AFund Focus Asset ClassEquity BenchmarkDow Jones U.S. Select Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings38 Fund Statistics Assets Under Management$673.70 million Average Daily Volume$62,551.30 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorCitibank, N.A. AdvisorBlackRock Fund Advisors CustodianCitibank, N.A. DistributorBlackRock Investments, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume1 Put Options15 Call Options1 Short Interest140,100 shs Miscellaneous Outstanding Shares10,100,000Beta0.58 Creation Unit50,000 Creation Fee$306.00 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. iShares U.S. Pharmaceuticals ETF ExpensesTypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.39%0.56%0.54%0.51%0.51%Other Expenses0.00%0.40%0.54%0.64%0.58%Total Expense0.39%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%Net Expense0.39%0.60%0.60%0.58%0.58% iShares U.S. Pharmaceuticals ETF (IHE) Holdings & ExposureTop 10 IHE HoldingsEli Lilly and Company(NYSE:LLY)Holding Weight: 24.36%Johnson & Johnson(NYSE:JNJ)Holding Weight: 21.70%Pfizer(NYSE:PFE)Holding Weight: 5.00%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 4.92%Zoetis(NYSE:ZTS)Holding Weight: 4.36%Royalty Pharma(NASDAQ:RPRX)Holding Weight: 4.21%Catalent(NYSE:CTLT)Holding Weight: 4.09%Viatris(NASDAQ:VTRS)Holding Weight: 4.01%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 3.63%Elanco Animal Health(NYSE:ELAN)Holding Weight: 3.42%IHE Sector ExposureIHE Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D. (Age 78)Independent Chairman of the Board of Trustees Michael Arthur Latham (Age 51)President, Trustee Jack Gee (Age 57)Chief Financial Officer, Treasurer Geoffrey D. FlynnChief Operating Officer, Executive Vice PresidentAmy Schioldager (Age 56)Executive Vice President Ira P. Shapiro (Age 52)Vice President, Chief Legal Officer Matt TuckerVice PresidentEilleen M. Clavere (Age 61)Secretary Cecilia H. Herbert (Age 68)Independent Trustee Charles A. Hurty (Age 73)Independent Trustee More ExecutivesSimilar ETFsiShares U.S. Healthcare Providers ETFNYSEARCA:IHFVanEck Pharmaceutical ETFNASDAQ:PPHVanEck Biotech ETFNASDAQ:BBHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHInstitutional OwnershipCetera Advisors LLCBought 3,905 shares on 5/24/2024Ownership: 0.039%Comerica BankBought 610 shares on 5/17/2024Ownership: 0.014%Kraft Davis & Associates LLCBought 13,088 shares on 5/16/2024Ownership: 0.241%Axxcess Wealth Management LLCBought 2,246 shares on 5/14/2024Ownership: 0.033%Patten & Patten Inc. TNBought 11,183 shares on 5/11/2024Ownership: 0.168%View All Institutional Transactions IHE ETF - Frequently Asked Questions How have IHE shares performed in 2024? iShares U.S. Pharmaceuticals ETF's stock was trading at $61.80 at the beginning of the year. Since then, IHE stock has increased by 5.2% and is now trading at $65.00. View the best growth stocks for 2024 here. What does IHE invest in? iShares U.S. Pharmaceuticals ETF is a equity fund issued by iShares. IHE focuses on health care investments and follows the Dow Jones U.S. Select Pharmaceuticals Index. The fund's investments total to approximately $673.70 million assets under management. What stocks does iShares U.S. Pharmaceuticals ETF hold? IHE invests in 38 holdings. Some of the stocks in their portfolio include Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Zoetis (ZTS), Royalty Pharma (RPRX), Catalent (CTLT), Viatris (VTRS), Bristol-Myers Squibb (BMY) and Elanco Animal Health (ELAN). What is the management fee for iShares U.S. Pharmaceuticals ETF? iShares U.S. Pharmaceuticals ETF's management fee is 0.39% and has no other recorded expenses or fee waivers. The net expense ratio for IHE is 0.39%. When did iShares U.S. Pharmaceuticals ETF's stock split? iShares U.S. Pharmaceuticals ETF's stock split on the morning of Thursday, March 7th 2024. The 3-1 split was announced on Thursday, March 7th 2024. The newly minted shares were distributed to shareholders after the closing bell on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Pharmaceuticals ETF investors own include United Parcel Service (UPS), CVS Health (CVS), Genuine Parts (GPC), Intel (INTC), Kinder Morgan (KMI), Wells Fargo & Company (WFC), Archer-Daniels-Midland (ADM), BP (BP) and Campbell Soup (CPB). Who are iShares U.S. Pharmaceuticals ETF's major shareholders? iShares U.S. Pharmaceuticals ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Accurate Wealth Management LLC (1.16%), Concord Investment Counsel Inc. (0.57%), Southern Capital Advisors LLC (0.38%), Commonwealth Equity Services LLC (0.35%), Kraft Davis & Associates LLC (0.24%) and Patten & Patten Inc. TN (0.17%). How do I buy shares of iShares U.S. Pharmaceuticals ETF? Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:IHE) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDigitizing the $11T commodities sector with one tiny stockResource Stock DigestThe only AI company to buyPorter & CompanyBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlacePresident Biden just made a shocking moveStansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.